Proper BPC-157 reconstitution and dosage calculations are critical for accurate peptide research. Using bacteriostatic water, researchers typically reconstitute lyophilized BPC-157 at standardized concentrations to ensure precise dosing — most commonly in the range of 200–800 mcg per day based on published animal study protocols. This guide covers the complete reconstitution process, dosage math, storage requirements, and best practices for maintaining peptide stability throughout a research protocol.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. As one of the most widely discussed peptides in the research community, understanding the complete BPC-157 dosage and reconstitution guide is essential for any researcher working with this compound. Accurate preparation directly affects experimental consistency and the reliability of observed outcomes.
This article provides a detailed, step-by-step reference for reconstituting lyophilized BPC-157 powder, calculating precise dosages, selecting appropriate solvents, and storing the peptide solution for optimal stability. All information is drawn from published preclinical literature and established peptide handling protocols.
What Is BPC-157 and Why Does Reconstitution Matter?
BPC-157 is a 15-amino-acid peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is typically supplied as a lyophilized (freeze-dried) powder to preserve stability during shipping and storage. In this dry form, the peptide has a significantly longer shelf life compared to its reconstituted liquid state.
Reconstitution — the process of dissolving the lyophilized powder into a sterile solution — is a necessary step before the peptide can be used in any research protocol. Improper reconstitution can degrade the peptide, introduce contamination, or produce inaccurate concentrations that compromise experimental results. Because BPC-157 is typically used at microgram-level doses, even small errors in preparation can lead to significant dosage discrepancies.
The two most common forms available to researchers are BPC-157 acetate salt and BPC-157 arginine salt (also called “stable form” or BPC-157 Stable). The acetate salt is more prevalent in research settings and is the form referenced throughout most published studies.
Materials Needed for BPC-157 Reconstitution
Before beginning the reconstitution process, researchers should gather the following materials to maintain a sterile and controlled environment:
- Lyophilized BPC-157 vial — commonly available in 2 mg or 5 mg quantities
- Bacteriostatic water (BAC water) — sterile water containing 0.9% benzyl alcohol as a preservative
- Alcohol swabs — for sterilizing vial stoppers before needle insertion
- Sterile syringes — typically 1 mL insulin syringes (U-100) for precise measurement
- Needles — 18–21 gauge for drawing BAC water; 27–31 gauge for subcutaneous research applications
Bacteriostatic water is the preferred solvent because the benzyl alcohol preservative inhibits microbial growth, allowing the reconstituted solution to be used over multiple days. Sterile water for injection is an alternative but should only be used for single-use preparations, as it lacks antimicrobial properties.
Step-by-Step Reconstitution Process
The following protocol outlines the standard reconstitution procedure for lyophilized BPC-157:
Step 1: Remove the BPC-157 vial and bacteriostatic water from storage. Allow both to reach room temperature naturally — do not heat or shake.
Step 2: Swab the rubber stopper of both the BPC-157 vial and the BAC water vial with an alcohol pad. Allow the alcohol to evaporate completely (approximately 15–30 seconds).
Step 3: Using a sterile syringe, draw the desired volume of bacteriostatic water. For most research applications, adding 1 mL or 2 mL of BAC water to the peptide vial produces a convenient working concentration.
Step 4: Insert the needle into the BPC-157 vial at an angle, directing the stream of water against the glass wall of the vial — not directly onto the lyophilized powder. This prevents damage to the peptide’s molecular structure from the force of the liquid stream.
Step 5: Allow the powder to dissolve naturally. Gently swirl the vial if needed, but never shake vigorously. BPC-157 typically dissolves within 30–60 seconds, producing a clear, colorless solution. If the solution appears cloudy or contains particulates, it may indicate contamination or degradation and should not be used.
BPC-157 Concentration and Dosage Calculation Tables
The concentration of the reconstituted solution depends on the amount of peptide in the vial and the volume of solvent added. The following table outlines common configurations:
| Peptide Amount | BAC Water Added | Concentration per mL | Concentration per 0.1 mL (10 IU) |
|---|---|---|---|
| 2 mg (2,000 mcg) | 1 mL | 2,000 mcg/mL | 200 mcg |
| 2 mg (2,000 mcg) | 2 mL | 1,000 mcg/mL | 100 mcg |
| 5 mg (5,000 mcg) | 1 mL | 5,000 mcg/mL | 500 mcg |
| 5 mg (5,000 mcg) | 2 mL | 2,500 mcg/mL | 250 mcg |
| 5 mg (5,000 mcg) | 2.5 mL | 2,000 mcg/mL | 200 mcg |
When using a standard U-100 insulin syringe (1 mL = 100 IU), each small tick mark represents 1 IU or 0.01 mL. This precision is essential for accurate microgram-level dosing.
Common BPC-157 Research Dosages in Published Literature
Dosage protocols for BPC-157 vary across published animal studies. The most frequently cited dosing range in the preclinical literature is 10 mcg/kg to 50 mcg/kg of body weight, administered either intraperitoneally (IP) or subcutaneously (SC). The table below provides a reference for how these weight-based dosages translate across different body weights:
| Body Weight | Dose at 10 mcg/kg | Dose at 20 mcg/kg | Dose at 50 mcg/kg |
|---|---|---|---|
| 60 kg (132 lbs) | 600 mcg/day | 1,200 mcg/day | 3,000 mcg/day |
| 70 kg (154 lbs) | 700 mcg/day | 1,400 mcg/day | 3,500 mcg/day |
| 80 kg (176 lbs) | 800 mcg/day | 1,600 mcg/day | 4,000 mcg/day |
| 90 kg (198 lbs) | 900 mcg/day | 1,800 mcg/day | 4,500 mcg/day |
| 100 kg (220 lbs) | 1,000 mcg/day | 2,000 mcg/day | 5,000 mcg/day |
It is important to note that these figures are extrapolations from animal research data. Direct human dosing equivalencies require allometric scaling (such as the FDA’s body surface area conversion), and straightforward linear scaling from rodent models does not accurately reflect interspecies pharmacokinetic differences. Many community-reported protocols reference daily dosages between 200 mcg and 800 mcg, often split into two administrations (morning and evening), but these figures lack robust clinical validation in human trials.
In the published rodent studies, BPC-157 has been investigated at these dosage ranges across protocol durations ranging from a single acute dose to continuous administration over 14–30 days, depending on the research endpoint being evaluated.
Administration Routes in Research
BPC-157 has been studied via multiple administration routes in the preclinical literature. Each route has distinct implications for bioavailability, onset, and localized versus systemic effects:
- Subcutaneous injection (SC): The most common route in peptide research. Injection is typically performed in the abdominal area or near the site of interest. This route offers relatively rapid absorption and systemic distribution.
- Intraperitoneal injection (IP): Frequently used in rodent studies. Provides rapid systemic absorption via the peritoneal membrane.
- Intragastric / Oral administration: BPC-157 has demonstrated notable stability in gastric conditions compared to many other peptides. Several studies have reported activity following oral administration in animal models, which is relatively unusual for a peptide of this size.
- Topical application: Some research has explored BPC-157 applied in cream or solution form directly to wound sites, though data on this route is more limited.
The gastric stability of BPC-157 is one of its more distinctive pharmacological properties. As a peptide originally isolated from gastric juice, it appears to maintain structural integrity in acidic environments where most peptides would undergo rapid hydrolysis. This characteristic has been documented in multiple studies from the Sikiric research group in Zagreb, Croatia, which has published the majority of BPC-157 literature to date.
Track your peptide protocol
Log every dose, cost, and observation in one organized spreadsheet.
Storage and Stability Guidelines
Proper storage is essential to maintaining BPC-157 potency throughout a research protocol. The following guidelines reflect best practices from peptide handling literature:
- Lyophilized (unreconstituted) BPC-157: Store at -20°C (freezer) for long-term storage. Can be stored at 2–8°C (refrigerator) for shorter periods of several weeks. Protect from light, heat, and moisture. Properly stored lyophilized peptide can remain stable for 24+ months.
- Reconstituted BPC-157: Store at 2–8°C (refrigerator). When reconstituted with bacteriostatic water, the solution is generally considered stable for up to 28–30 days. Do not freeze reconstituted peptide solutions, as freeze-thaw cycles can cause protein aggregation and degradation.
- General handling: Minimize repeated needle punctures through the vial stopper. Avoid leaving the vial at room temperature for extended periods. Always swab the stopper with alcohol before each access.
Researchers should visually inspect the reconstituted solution before each use. A clear, colorless solution indicates likely stability. Any cloudiness, discoloration, or visible particles suggests degradation, and the solution should be discarded.
Common Reconstitution Mistakes to Avoid
Even experienced researchers can make errors during peptide preparation. The following are the most frequently encountered mistakes with BPC-157 reconstitution:
1. Injecting water directly onto the powder: The force of the liquid stream can physically damage peptide molecules. Always direct the solvent stream down the inner glass wall of the vial.
2. Shaking the vial vigorously: Aggressive agitation can cause denaturation and foaming. Gentle swirling is sufficient to dissolve the lyophilized cake.
3. Using the wrong solvent: Normal saline (0.9% NaCl) is not the same as bacteriostatic water. While both are sterile, they have different compositions and intended uses. Bacteriostatic water is the standard choice for multi-use peptide reconstitution.
4. Miscalculating concentrations: Always double-check the math. A 5 mg vial reconstituted with 2 mL yields 2,500 mcg/mL — not 2,000 mcg/mL. Using a peptide reconstitution calculator can help prevent dosing errors.
5. Storing at improper temperatures: Leaving reconstituted BPC-157 at room temperature or exposing it to direct sunlight will accelerate degradation significantly.
Quality Considerations and Peptide Purity
The reliability of any BPC-157 research protocol depends heavily on the quality and purity of the starting material. Researchers should prioritize sourcing peptides that meet the following criteria:
- Purity ≥98% as verified by High-Performance Liquid Chromatography (HPLC)
- Mass spectrometry (MS) verification confirming the correct molecular weight (1,419.53 g/mol for the free base)
- Certificate of Analysis (COA) from an independent third-party laboratory
- Proper lyophilization — the peptide should appear as a white to off-white powder or cake
Third-party testing is particularly important in the peptide market, where product quality can vary significantly between suppliers. A legitimate COA should include HPLC purity data, MS confirmation, and amino acid sequ